Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences Co., Ltd. has announced the composition of its board of directors, featuring a blend of executive, non-executive, and independent directors. The board has also formed four specialized committees to oversee various aspects of corporate governance, including audit, nomination, remuneration, and strategic initiatives. This organizational structure reflects the company’s commitment to robust management and strategic oversight.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.